all report title image

GLUCOSE SENSOR MARKET ANALYSIS

Glucose Sensor Market, by Product Type (Non-invasive (Optical Sensors and Transdermal Sensors), Invasive (Intravenous Implantable, Micro Dialysis, and Subcutaneous Sensor), and Minimally Invasive (Micro Pore/ Micro Needles)), by Technology (Polarimetry, Raman Spectroscopy, (Near) Infrared Spectroscopy, MIR Spectroscopy, Impedance Spectroscopy, Fluorescence, Photo-Acoustic Spectroscopy, Optical Coherence Tomography, Skin Suction Blister Technique, Sonophoresis, and Reverse Iontophoresis), by Distribution Channel (Hospitals, Clinics, Home Care Settings, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Nov 2024
  • Code : CMI2490
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Regional Analysis

Global Glucose Sensor Market: Regional Analysis

On the basis of region, the global glucose sensor market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to witness significant growth in the glucose sensor market, owing to presence of major players and launch of new products in this region. For instance, in July 2018, Abbott Laboratories received the U.S. Food and Drug Administration (FDA) approval for its FreeStyle Libre 14 day Flash Glucose Monitoring System. The system allows a  diabetic patient to wear the sensor up to 14 days and offers results with high accuracy. It is the first continuous glucose monitoring system that can be used by diabetic patients to take diabetes treatment decisions without using a blood sample from the fingertip. The systems eliminates the need for fingerstick testing by using a small sensor wire inserted below the skin’s surface. This sensor continuously measures and monitors glucose levels.

Furthermore, Asia Pacific glucose sensor market is expected to witness significant growth over the forecast period, owing to increasing diabetes healthcare spending in the region. For instance, according to the International Diabetes Federation’ (IDF) estimates, in 2017, diabetic healthcare spending in Asia Pacific was US$ 241 million.

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.